CJC-1295 and Sermorelin are GHRH analogs that act through the GHRH receptor
2 Recognizing the need for comprehensive, person-centered obesity care, the World Health Organization's 2026 global guidelines explicitly recommend pairing GLP-1 therapies with intensive behavioral interventions, including weekly counseling sessions and structured goal setting for diet and physical activity
The Bottom Line While Ozempic can be a powerful tool for weight loss and diabetes management, it may also contribute to significant lean mass loss
While semaglutide isnt a one-size-fits-all solution, its definitely worth exploring as an innovative, science-backed method and as an adjunct to traditional methods of weight loss
Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies, including Hims & Hers and other compounding pharmacies, as similar alternatives to FDA-approved drugs. The agency said the actions are intended to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The agency also emphasized ongoing concerns around promotional claims and direct-to-consumer messaging, building on the The FDA is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025, the agency said
The master antioxidant